关贸总协定
突变体
异位表达
造血
生物
髓样
粒细胞生成
髓系白血病
GATA1公司
癌症研究
突变
锌指
CEBPA公司
转录因子
K562细胞
GATA转录因子
白血病
细胞生物学
遗传学
干细胞
细胞培养
基因表达
基因
发起人
作者
Enric Redondo Monte,Georg Leubolt,Roland Windisch,Paul Kerbs,Sayantanee Dutta,Theresa Sippenauer,Rouzanna Istvánffy,Robert A.J. Oostendorp,Linping Chen-Wichmann,Tobias Herold,Monica Cusan,Gunnar Schotta,Christian Wichmann,Philipp A. Greif
标识
DOI:10.1016/j.exphem.2022.02.002
摘要
GATA2 zinc-finger (ZF) mutations are associated with distinct entities of myeloid malignancies. The specific distribution of these mutations points toward different mechanisms of leukemogenesis depending on the ZF domain affected. In this study, we compared recurring somatic mutations in ZF1 and ZF2. All tested ZF mutants disrupted DNA binding in vitro. In transcription assays, co-expression of FOG1 counteracted GATA2-dependent transcriptional activation, while a variable response to FOG1-mediated repression was observed for individual GATA2 mutants. In primary murine bone marrow cells, GATA2 wild-type (WT) expression inhibited colony formation, while this effect was reduced for both mutants A318T (ZF1) and L359V (ZF2) with a shift toward granulopoiesis. In primary human CD34+ bone marrow cells and in the myeloid cell line K562, ectopic expression of GATA2 L359V, but not A318T or G320D, caused a block of erythroid differentiation accompanied by downregulation of GATA1, STAT5B, and PLCG1. Our findings may explain the role of GATA2 L359V during the progression of chronic myeloid leukemia and the collaboration of GATA2 ZF1 alterations with CEBPA double mutations in erythroleukemia.
科研通智能强力驱动
Strongly Powered by AbleSci AI